Research indicates that trans men using testosterone therapy have approximately five times the risk of developing fungal acne compared to the general population. This heightened susceptibility stems from the physiological changes testosterone induces—specifically increased sebum production, altered skin microbiome composition, and shifts in sweat gland activity that create an environment where fungal organisms like Malassezia thrive. For example, a trans man who begins testosterone therapy at age 25 might experience sudden breakouts of small, uniform pustules on the chest and back within the first few months, a presentation distinctly different from bacterial acne and often misidentified as conventional acne by practitioners unfamiliar with this pattern. The increased risk is not a personal failing or the result of poor hygiene.
Instead, it represents a predictable dermatological consequence of hormonal transition. Understanding this connection matters because fungal acne responds poorly to standard acne treatments like benzoyl peroxide and antibiotics—and using these ineffective treatments can actually worsen the condition while delaying proper care. The difference in treatment approach is significant: where someone with bacterial acne might benefit from oral antibiotics, a trans man with fungal acne requires antifungal medications, which work through entirely different mechanisms. This heightened risk period typically lasts throughout active testosterone use, though some individuals report stabilization after the first 1-2 years as their skin barrier adapts. Awareness of this vulnerability allows for early recognition and appropriate intervention, preventing the months or years of frustration that often occur when fungal acne is repeatedly treated as bacterial acne.
Table of Contents
- Why Does Testosterone Increase Fungal Acne Susceptibility in Trans Men?
- How Fungal Acne Differs From Bacterial Acne and Why It’s Often Misdiagnosed
- The Skin Microbiome Changes During Testosterone Therapy
- Treatment Approaches and Practical Management Strategies
- Management of Sebum Production and Humidity
- Differentiating Fungal Acne From Other Skin Conditions
- Future Outlook and Long-Term Management Perspectives
- Conclusion
Why Does Testosterone Increase Fungal Acne Susceptibility in Trans Men?
Testosterone dramatically increases sebaceous gland activity, causing the skin to produce substantially more sebum—the oily substance that feeds fungal organisms. This hormonal effect mimics what occurs during puberty in cisgender boys, except the shift happens over weeks or months rather than years, creating a rapid environmental change on the skin surface. Malassezia, the yeast species most commonly responsible for fungal acne, depends on sebum as a nutrient source; elevated sebum production essentially creates an all-you-can-eat buffet for these organisms. Additionally, testosterone alters the composition of the skin microbiome itself. While the bacterial flora shifts toward a more masculine-typical profile, the immune tolerance for fungal organisms increases.
The skin’s natural pH changes, and certain antimicrobial peptides that normally suppress fungal growth are downregulated. A trans man might notice this shift by experiencing acne in locations he never had breakouts before—shoulders, upper back, and chest become common sites because sweat and sebum accumulation in these areas are particularly favorable to Malassezia growth. The sweat gland response to testosterone also matters. Trans men often experience increased perspiration, particularly during physical activity, creating moisture that fungal organisms require for proliferation. Combined with the higher sebum production, this creates humid micro-environments even on relatively dry-looking skin.
How Fungal Acne Differs From Bacterial Acne and Why It’s Often Misdiagnosed
fungal acne presents a distinctly different appearance than bacterial acne, yet practitioners frequently misidentify it. The lesions are typically small, uniform, and tightly clustered—almost monomorphic in appearance—whereas bacterial acne usually shows varied lesion sizes and distributions. Fungal acne pustules are usually 1-2mm in diameter and don’t tend to form the larger comedones or cystic lesions common in bacterial acne. The distribution pattern also differs: fungal acne clusters on the chest, upper back, shoulders, and sometimes the upper arms, while bacterial acne shows a more varied distribution. A critical limitation in diagnosis is that fungal acne may not improve with standard acne treatments.
When a trans man receives a prescription for benzoyl peroxide or oral doxycycline and sees no improvement after 2-3 months, the assumption is often that the acne is severe or resistant—leading to escalation to stronger antibiotics or Accutane. However, these treatments are fundamentally ineffective for fungal infections and may actually exacerbate the condition. Antibiotics can disrupt the bacterial flora that normally keep Malassezia in check, potentially worsening fungal acne while simultaneously selecting for antibiotic-resistant bacteria. The warning here is clear: extended use of antibiotics for fungal acne represents both wasted time and potential harm. Proper diagnosis requires either a clinical evaluation by a dermatologist familiar with this presentation or sometimes a KOH (potassium hydroxide) preparation to visualize fungal elements microscopically. Many urgent care clinics and general practitioners lack familiarity with fungal acne in trans populations and may misdiagnose it as severe bacterial acne, leading to inappropriate treatment escalation.
The Skin Microbiome Changes During Testosterone Therapy
Testosterone therapy fundamentally remodels the composition of bacteria and fungi living on the skin. The shift includes an increase in lipophilic (fat-loving) bacteria like Propionibacterium acnes, but more significantly, it creates conditions where Malassezia species transition from being controlled minority organisms to dominant players in the skin ecosystem. The microbiome of someone on testosterone begins to resemble the microbiome of cisgender men—which includes higher Malassezia colonization as a normal feature. This shift has an important implication: the skin’s natural defenses against fungal overgrowth are temporarily weakened.
Certain bacterial species produce compounds that inhibit Malassezia growth; when testosterone alters the bacterial population structure, these natural fungistatic compounds may be reduced. Additionally, testosterone influences the expression of antimicrobial peptides in the skin, and some of these peptides have antifungal activity. The immune system’s tolerance for fungal organisms increases as part of the normal hormonal transition. A specific example: a trans man might be fungal-acne-free before starting testosterone, then develop breakouts within 6-12 weeks of initiation, corresponding to the window when sebum production is rapidly increasing but the skin microbiome hasn’t fully stabilized to a new equilibrium. Some individuals report that the fungal acne gradually improves after 12-24 months, potentially because the skin barrier and immune responses have adapted to the new hormonal milieu.
Treatment Approaches and Practical Management Strategies
The first-line treatment for fungal acne is typically topical antifungal medication, most commonly azoles like ketoconazole or fluconazole, or alternatively selenium sulfide. These work through completely different mechanisms than benzoyl peroxide or antibiotics—they disrupt the fungal cell membrane or inhibit fungal protein synthesis. For many trans men, a topical antifungal cream or lotion applied twice daily produces visible improvement within 2-3 weeks, providing hope and relief after months of ineffective standard acne treatments. However, a significant limitation is that relapse is common once antifungal treatment is stopped. Because the underlying hormonal environment remains favorable to fungal growth, fungal acne often recurs when treatment is discontinued.
This differs from bacterial acne, where a course of antibiotics may provide lasting benefit. Many trans men find they need to continue maintenance antifungal therapy—either intermittently (a few weeks per month) or consistently—as long as they’re using testosterone. Some individuals rotate between different antifungal agents to prevent resistance, while others find that one medication remains effective long-term. Comparison: A trans man using oral doxycycline for bacterial acne might take it for 3-6 months and then stop with sustained improvement. The same person using ketoconazole shampoo or cream for fungal acne may need to use it indefinitely or face recurrent breakouts within weeks of stopping. Understanding this difference in relapse patterns helps set realistic expectations and prevents the frustration of thinking the fungal acne is “returning” or “getting worse”—it’s actually a feature of the treatment being necessary as long as the hormonal context remains.
Management of Sebum Production and Humidity
Controlling sebum production becomes a critical part of fungal acne management, though this is more complex than simple hygiene. Over-washing or using overly drying products can paradoxically worsen fungal acne by triggering increased sebum production as a compensatory response. The skin barrier integrity also matters: when the barrier is compromised by harsh treatments, inflammation increases and the local immune environment becomes less able to suppress fungal organisms. A practical warning: many products marketed for acne—particularly those containing salicylic acid or benzoyl peroxide—can be irritating and barrier-disrupting for people managing fungal acne. Instead, gentle cleansing with a non-stripping cleanser, followed by a lightweight, non-comedogenic moisturizer, provides a better foundation.
Some individuals benefit from using a mild exfoliant 2-3 times per week to prevent buildup of dead skin cells and sebum, but this must be balanced against irritation risk. Humidity management also matters. Trans men who sweat heavily during exercise or live in humid climates may need additional antifungal maintenance during high-humidity periods. Changing out of sweaty clothes promptly, using breathable fabrics, and keeping skin dry (without over-drying it) all help suppress fungal growth. A limitation here is that these measures alone are rarely sufficient to clear fungal acne in trans men on testosterone—they work best as adjuncts to antifungal medication.
Differentiating Fungal Acne From Other Skin Conditions
Fungal acne can sometimes be confused with other conditions, including folliculitis (bacterial infection of hair follicles), miliaria (heat rash), or rosacea-like eruptions. The uniform, small size of fungal acne lesions is usually the key distinguishing feature, but without microscopic examination, clinical misidentification is common. Some individuals have concurrent fungal acne and bacterial folliculitis, making diagnosis even more complex.
Interestingly, some trans men report that their fungal acne improves dramatically during cold months or when they travel to low-humidity environments, then recurs when humidity increases. This seasonal variation is a helpful diagnostic clue pointing toward fungal rather than bacterial acne. Tracking patterns in breakouts—whether they worsen with sweating, improve with antifungals, or show seasonal variation—provides crucial information for both the individual and their healthcare provider.
Future Outlook and Long-Term Management Perspectives
As testosterone therapy becomes more common and dermatologists gain greater familiarity with trans men’s health, earlier recognition of fungal acne should reduce the frustrating delays in diagnosis. Some dermatologists now routinely screen for fungal acne in trans men presenting with acne concerns, rather than assuming bacterial acne and prescribing antibiotics by default. This shift in clinical awareness represents meaningful progress for trans men seeking effective acne care.
Long-term management remains an individual decision. Some trans men view intermittent antifungal use as a manageable trade-off for the benefits of testosterone therapy. Others explore whether alternative forms of testosterone delivery—such as lower doses or different formulations—might reduce sebum production and fungal acne risk, though evidence on this is limited. The key insight is that fungal acne during testosterone therapy is not a sign that testosterone is “wrong” or inappropriate; it’s a predictable physiological response that can be managed with proper knowledge and treatment.
Conclusion
Trans men on testosterone face a substantially elevated risk of developing fungal acne due to increased sebum production, microbiome shifts, and altered immune tolerance for fungal organisms. This is not a rare complication or a sign of poor skincare—it’s a common, physiologically driven consequence of hormonal transition that affects roughly one in five trans men using testosterone. The critical difference between fungal and bacterial acne is not academic; it directly determines which treatments will work and which will waste time or cause harm.
Proper management begins with recognition. If you’re a trans man experiencing acne that isn’t improving with standard treatments, consider the possibility of fungal acne and seek evaluation by a dermatologist familiar with this presentation. If you’re starting testosterone therapy, understanding this risk allows you to seek early diagnosis if breakouts develop, rather than spending months on ineffective antibiotics. Effective antifungal treatment exists, but it requires the right diagnosis and realistic expectations about long-term management—which is achievable and allows most trans men to manage their skin successfully while on testosterone.
